Key facts
- This page summarizes Mala Murthy's Form 4 filing for Teladoc Health, Inc. (TDOC).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 05 Dec 2023, 16:07.
Mala Murthy - 01 Dec 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)
- Reporting relationship
- CHIEF FINANCIAL OFFICER
- Issuer ticker
- TDOC
- Reported as of
- 01 Dec 2023
- Net transaction value
- -$56,782
- SEC form
- 4
- Accepted by SEC
- 05 Dec 2023, 16:07:49 UTC
- Prior SEC filing
- 06 Sep 2023
- Next SEC filing
- 05 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Adam C. Vandervoort, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mala Murthy filed Form 4 for Teladoc Health, Inc. (TDOC) on 05 Dec 2023.
Change
- Previous filing in this sequence was filed on 06 Sep 2023.
- Current net transaction value: -$56,782.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TDOC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +3,369
- Change %
- +7.2%
- Price
- Shares after
- 50,276
- Date
- 01 Dec 2023
- Ownership
- Direct
- Footnotes
- F1
TDOC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,043
- Change %
- +4.1%
- Price
- Shares after
- 52,319
- Date
- 01 Dec 2023
- Ownership
- Direct
- Footnotes
- F1
TDOC
transaction
Common Stock
Sale
- Transaction value
- $56,782
- Shares
- -3,004
- Change %
- -5.7%
- Price
- $18.90
- Shares after
- 49,315
- Date
- 04 Dec 2023
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TDOC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -3,369
- Change %
- -17%
- Price
- $0.000000
- Shares after
- 16,845
- Date
- 01 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,369
- Exercise price
- Footnotes
- F1, F3
TDOC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,043
- Change %
- -14%
- Price
- $0.000000
- Shares after
- 12,264
- Date
- 01 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,043
- Exercise price
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Footnote F2
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
Footnote F3
On March 1, 2022, the reporting person was granted 40,426 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Footnote F4
On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.